Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 26.02.2024 1 Am J Kidney Dis 9 Diabet Med 3 Diabetes 7 Diabetes Res Clin Pract 1 Intern Med 2 J Autoimmun 7 J Clin Endocrinol Metab 2 J Neuroimmunol 4 J Neurol 1 J Pediatr 2 Kidney Int 3 Lancet 4 Lancet Neurol 6 Mult Scler 2 N Engl J Med 1 Neurologia (Engl Ed) 1 Neurology 1 PLoS One 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Kidney Dis

1. TANG C, Chen P, Si FL, Lv JC, et al
   Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.
   Am J Kidney Dis. 2024 Feb 14:S0272-6386(24)00609.
   PubMed         Abstract available
   
   

   
   Diabet Med

2. HENDRIECKX C, Husin HM, Russell-Green S, Halliday JA, et al
   The Diabetes Management Experiences Questionnaire: Psychometric validation among adults with type 1 diabetes.
   Diabet Med. 2023 Aug 10:e15195. doi: 10.1111/dme.15195.
   PubMed         Abstract available
   
   
3. TANG TS, Yip AKW, Klein G, Moore L, et al
   Training peers to deliver mental health support to adults with Type 1 diabetes using the REACHOUT Mobile App.
   Diabet Med. 2023 Aug 27:e15210. doi: 10.1111/dme.15210.
   PubMed         Abstract available
   
   
4. KELLY RC, Holt RIG, Desborough L, Majidi S, et al
   The Psychosocial Burdens of Living with Diabetes.
   Diabet Med. 2023 Sep 3:e15219. doi: 10.1111/dme.15219.
   PubMed         Abstract available
   
   
5. MOSER O, Pemberton JS
   Rethinking the safety and efficacy assessment of (Hybrid) Closed Loop systems: Should we promote the need for a minimum of exercise data within the regulatory approval?
   Diabet Med. 2024;41:e15305.
   PubMed        
   
   
6. ZHOU Y, Sardana D, Kuroko S, Haszard JJ, et al
   Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomi
   Diabet Med. 2024 Jan 10:e15280. doi: 10.1111/dme.15280.
   PubMed         Abstract available
   
   
7. WIBAEK R, Ibfelt EH, Andersen GS, Hulman A, et al
   Heterogeneity in glycaemic control in children and adolescents with type 1 diabetes: A latent class trajectory analysis of Danish nationwide data.
   Diabet Med. 2023 Dec 29:e15275. doi: 10.1111/dme.15275.
   PubMed         Abstract available
   
   
8. GRAMMES J, Schmid S, Bozkurt L, Heinemann L, et al
   Continuous glucose monitoring in older adults with diabetes: Data from the diabetes prospective follow-up (DPV) registry.
   Diabet Med. 2023 Nov 27:e15261. doi: 10.1111/dme.15261.
   PubMed         Abstract available
   
   
9. LEELARATHNA L, Sutton CJ, Evans ML, Neupane S, et al
   Intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: A subgroup analysis from the FLASH-UK study.
   Diabet Med. 2023 Oct 28:e15249. doi: 10.1111/dme.15249.
   PubMed         Abstract available
   
   
10. ELLIOTT RA, Rogers G, Evans ML, Neupane S, et al
    Estimating the cost effectiveness of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in England.
    Diabet Med. 2023 Sep 26:e15232. doi: 10.1111/dme.15232.
    PubMed         Abstract available
    
    

    
    Diabetes

11. KIM YK, Kim YR, Wells KL, Sarbaugh D, et al
    PTPN2 Regulates Metabolic Flux to Affect beta-Cell Susceptibility to Inflammatory Stress.
    Diabetes. 2024;73:434-447.
    PubMed         Abstract available
    
    
12. KUGATHASAN L, Sridhar VS, Lovblom LE, Matta S, et al
    Interactive effects of Empagliflozin and Hyperglycemia on Urinary Amino Acids in Individuals with Type 1 Diabetes.
    Diabetes. 2023 Nov 28:db230694. doi: 10.2337/db23-0694.
    PubMed         Abstract available
    
    
13. KASINATHAN D, Guo Z, Sarver DC, Wong GW, et al
    Cell-surface ZnT8 antibody prevents and reverses autoimmune diabetes in mice.
    Diabetes. 2024 Feb 22:db230568. doi: 10.2337/db23-0568.
    PubMed         Abstract available
    
    

    
    Diabetes Res Clin Pract

14. NEUMAN V, Vavra D, Drnkova L, Pruhova S, et al
    Introduction of continuous glucose monitoring (CGM) is a key factor in decreasing HbA1c in war refugee children with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;208:111118.
    PubMed         Abstract available
    
    
15. STOCCO A, Trawley S, Kong YW, Yuan CY, et al
    "You can hide it if you want to, you can let it be seen if you want to": A qualitative study of the lived experiences of Australian adults with type 1 diabetes using the Omnipod DASH(R) system.
    Diabetes Res Clin Pract. 2024;208:111123.
    PubMed         Abstract available
    
    
16. HOOD KK, Schneider-Utaka AK, Reed ZW, Buckingham BA, et al
    Patient reported outcomes (PROs) and user experiences of young children with type 1 diabetes using t:slim X2 insulin pump with control-IQ technology.
    Diabetes Res Clin Pract. 2024;208:111114.
    PubMed         Abstract available
    
    
17. AHOLA AJ, Tikkanen-Dolenc H, Harjutsalo V, Groop PH, et al
    Clustering of risk behaviours and associations between risk behaviours and cardio-metabolic risk factors in adult individuals with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;208:111115.
    PubMed         Abstract available
    
    
18. ALI L, Alhassan M
    Challenges in achieving adequate glycemic control among children with type 1 diabetes mellitus in a resource-limited setting: A cross-sectional study from Sudan.
    Diabetes Res Clin Pract. 2024;208:111113.
    PubMed         Abstract available
    
    
19. BURKHARDT MS, Pirri C, Summers MA, Barrie P, et al
    Group-based behaviour therapy improves self-care, glycaemic control and distress in adults with type 1 diabetes.
    Diabetes Res Clin Pract. 2024;208:111095.
    PubMed         Abstract available
    
    
20. ZHANG P, Zhang Z, Zhong J, Zheng X, et al
    Cardiovascular diseases consequences of type 1, type 2 diabetes mellitus and glycemic traits: A Mendelian randomization study.
    Diabetes Res Clin Pract. 2024;208:111094.
    PubMed         Abstract available
    
    

    
    Intern Med

21. SUMICHIKA Y, Temmoku J, Saito K, Yoshida S, et al
    New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review.
    Intern Med. 2024 Feb 19. doi: 10.2169/internalmedicine.3211.
    PubMed         Abstract available
    
    

    
    J Autoimmun

22. VERGOUWEN DPC, van Beek AA, de Hoog J, de Boer JH, et al
    The enigma of sclera-specific autoimmunity in scleritis.
    J Autoimmun. 2024;144:103178.
    PubMed         Abstract available
    
    
23. HOXHA A, Perin N, Lovisotto M, Calligaro A, et al
    Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study.
    J Autoimmun. 2024;144:103180.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

24. MENON JC, Singh P, Archana A, Singh P, et al
    High frequency of recessive WFS1 mutations among Indian children with islet antibody-negative type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Nov 1:dgad644. doi: 10.1210.
    PubMed         Abstract available
    
    
25. WU Q, Zhou J, Fang W, Jiang WH, et al
    Structural and functional brain changes after glucocorticoid therapy in thyroid-associated ophthalmopathy.
    J Clin Endocrinol Metab. 2023 Oct 21:dgad626. doi: 10.1210.
    PubMed         Abstract available
    
    
26. KIM KM, Kim KJ, Han K, Rhee Y, et al
    Associations Between Physical Activity and the Risk of Hip Fracture Depending on Glycemic Status: A Nationwide Cohort Study.
    J Clin Endocrinol Metab. 2024;109:e1194-e1203.
    PubMed         Abstract available
    
    
27. LUI DTW, Wong CKH, Man KKC
    Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad614. doi: 10.1210.
    PubMed        
    
    
28. MULLER I, Consonni D, Crivicich E, di Marco F, et al
    Response to Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad616. doi: 10.1210.
    PubMed        
    
    
29. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    PubMed         Abstract available
    
    
30. FU J, Guan H
    The Impact of Salt Iodization on the Occurrence of Hyperthyroidism: Evidence from General Populations to Pregnant Women.
    J Clin Endocrinol Metab. 2023 Aug 31:dgad522. doi: 10.1210.
    PubMed        
    
    

    
    J Neuroimmunol

31. GALETTA K, Ham AS, Vishnevetsky A, Bhattacharyya S, et al
    Disease modifying therapy in the treatment of tumefactive multiple sclerosis: A retrospective cohort study.
    J Neuroimmunol. 2024;388:578299.
    PubMed         Abstract available
    
    
32. LI X, Chen JJ, Hur M, Paton GR, et al
    Papillitis associated with IgLON5 autoimmunity: A novel clinical phenotype.
    J Neuroimmunol. 2024;388:578312.
    PubMed         Abstract available
    
    

    
    J Neurol

33. OHNARI K, Hashimoto T, Iwanaka Y, Ohnari K, et al
    Dramatic improvement in refractory myasthenia gravis with eculizumab treatment: a case report.
    J Neurol. 2024 Feb 23. doi: 10.1007/s00415-024-12245.
    PubMed        
    
    
34. GREGULETZ P, Plotz M, Baade-Buttner C, Bien CG, et al
    Different pain phenotypes are associated with anti-Caspr2 autoantibodies.
    J Neurol. 2024 Feb 22. doi: 10.1007/s00415-024-12224.
    PubMed         Abstract available
    
    
35. CUTILLO G, Rubin M, d'Amore G, Malcangi M, et al
    Infratentorial posterior reversible encephalopathy syndrome in INFbeta1a-treated multiple sclerosis patient.
    J Neurol. 2024 Feb 22. doi: 10.1007/s00415-024-12226.
    PubMed        
    
    
36. BIANCHI A, Matranga D, Patti F, Maniscalco L, et al
    The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT).
    J Neurol. 2024 Feb 16. doi: 10.1007/s00415-024-12214.
    PubMed         Abstract available
    
    

    
    J Pediatr

37. YAGUCHI A, Nakagawa M, Endo A, Fujimura J, et al
    Green Urine in the Diaper: A Key Indicator for Diagnosing Hemolytic Anemia.
    J Pediatr. 2023 Nov 23:113856. doi: 10.1016/j.jpeds.2023.113856.
    PubMed        
    
    

    
    Kidney Int

38. WANG H, Zuiani J, Coates Ao PT, Xia Y, et al
    Reconstructing the interface between the human intestine and immune system: potential to advance mechanistic studies in IgA nephropathy.
    Kidney Int. 2024;105:423-426.
    PubMed        
    
    
39. VOINESCU CD, Mozere M, Genovese G, Downie ML, et al
    A Neanderthal haplotype introgressed into the human genome confers protection against membranous nephropathy.
    Kidney Int. 2024 Feb 14:S0085-2538(24)00073-5. doi: 10.1016/j.kint.2024.
    PubMed         Abstract available
    
    

    
    Lancet

40. KRONBICHLER A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, et al
    Diagnosis and management of ANCA-associated vasculitis.
    Lancet. 2024;403:683-698.
    PubMed         Abstract available
    
    
41. VAN DER HELM-VAN MIL AHM
    Abatacept in individuals with autoantibody-positive arthralgia at risk for rheumatoid arthritis.
    Lancet. 2024 Feb 14:S0140-6736(24)00055-2. doi: 10.1016/S0140-6736(24)00055.
    PubMed        
    
    
42. CHAKER L, Cooper DS, Walsh JP, Peeters RP, et al
    Hyperthyroidism.
    Lancet. 2024 Jan 23:S0140-6736(23)02016-0. doi: 10.1016/S0140-6736(23)02016.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

43. MUNOZ-LOPETEGI A, Guasp M, Prades L, Martinez-Hernandez E, et al
    Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
    Lancet Neurol. 2024;23:256-266.
    PubMed         Abstract available
    
    
44. RAMDAS S, Palace J
    PROMISE of low-cost immunosuppressants for myasthenia gravis.
    Lancet Neurol. 2024;23:223-225.
    PubMed        
    
    
45. NARAYANASWAMI P, Sanders DB, Thomas L, Thibault D, et al
    Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study.
    Lancet Neurol. 2024;23:267-276.
    PubMed         Abstract available
    
    
46. CHATAWAY J, Williams T, Li V, Marrie RA, et al
    Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges.
    Lancet Neurol. 2024;23:277-301.
    PubMed         Abstract available
    
    

    
    Mult Scler

47. BOAVENTURA M, Sastre-Garriga J, Rimkus CM, Rovira A, et al
    T1/T2-weighted ratio: A feasible MRI biomarker in multiple sclerosis.
    Mult Scler. 2024 Feb 22:13524585241233448. doi: 10.1177/13524585241233448.
    PubMed         Abstract available
    
    
48. EMMA C, Vesela P, Kay P, Huseyin H, et al
    Psoriasiform dermatitis following ocrelizumab in relapsing-remitting multiple sclerosis: Case report and literature review.
    Mult Scler. 2024 Feb 22:13524585241232277. doi: 10.1177/13524585241232277.
    PubMed         Abstract available
    
    
49. ERCAN MB, Kocer B, Altiparmak T, Arslan I, et al
    Responsiveness to pembrolizumab in severe early-onset natalizumab associated PML-IRIS in patient with relapsing-remitting multiple sclerosis.
    Mult Scler. 2024 Feb 22:13524585241231655. doi: 10.1177/13524585241231655.
    PubMed        
    
    
50. JALALEDDINI K, Bermel RA, Talente B, Weinstein D, et al
    A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis.
    Mult Scler. 2024 Feb 19:13524585241227372. doi: 10.1177/13524585241227372.
    PubMed         Abstract available
    
    
51. ROCCA MA, D'Amore G, Valsasina P, Tedone N, et al
    2.5-Year changes of connectivity dynamism are relevant for physical and cognitive deterioration in multiple sclerosis.
    Mult Scler. 2024 Feb 19:13524585241231155. doi: 10.1177/13524585241231155.
    PubMed         Abstract available
    
    
52. ROVARIS M, Toselli E, Mendozzi L, Di Tella S, et al
    Eye movement desensitization and reprocessing for depressed individuals with multiple sclerosis: A pilot study.
    Mult Scler. 2024 Feb 19:13524585241230236. doi: 10.1177/13524585241230236.
    PubMed         Abstract available
    
    

    
    N Engl J Med

53. MULLER F, Taubmann J, Bucci L, Wilhelm A, et al
    CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
    N Engl J Med. 2024;390:687-700.
    PubMed         Abstract available
    
    
54. ISAACS JD
    CAR T Cells - A New Horizon for Autoimmunity?
    N Engl J Med. 2024;390:758-759.
    PubMed        
    
    

    
    Neurologia (Engl Ed)

55. GARCIA ESTEVEZ DA, Pinal Osorio I, Pato Pato A
    Alemtuzumab and autoimmune polyglandular syndrome with type 1 diabetes mellitus.
    Neurologia (Engl Ed). 2024 Feb 20:S2173-5808(24)00044.
    PubMed        
    
    

    
    Neurology

56. YOUNG A, Johnston JL
    Pearls & Oy-sters: Ocular Myasthenia Gravis: Central Ocular Motor Signs and Unilateral Visual Loss Caused by the Great Neuro-Ophthalmologic Impersonator.
    Neurology. 2024;102:e209260.
    PubMed         Abstract available
    
    

    
    PLoS One

57. JEONG HS, Chun BC
    COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barre Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
    PLoS One. 2024;19:e0297902.
    PubMed         Abstract available
    
    

    
    Thyroid

58. DUNTAS LH
    Reassessing Selenium for the Management of Hashimoto's Thyroiditis: the Selini* shines bright for AIT patients.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2024.0078.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.